Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Howard

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Biomaterials|February 26, 2022
Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruptionPhillip W Janowicz, Zachary H Houston, Jens Bunt, et al.
Scientific Reports|July 20, 2023
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damageMichael Agrez, Mark Stephen Rybchyn, Warusavithana Gunawardena Manori De Silva, et al.
Advanced Healthcare Materials|March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesJiwei Cui, Yi Ju, Zachary H Houston, et al.
Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Biomaterials|February 26, 2022
Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruptionPhillip W Janowicz, Zachary H Houston, Jens Bunt, et al.
Scientific Reports|July 20, 2023
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damageMichael Agrez, Mark Stephen Rybchyn, Warusavithana Gunawardena Manori De Silva, et al.
Advanced Healthcare Materials|March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesJiwei Cui, Yi Ju, Zachary H Houston, et al.
Science Translational Medicine|May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.
Pageof 8